Shraddha S. Sawant

Shraddha S. Sawant

Auto-generated profile, based on publicly available information

Shraddha S. Sawant

Department of Chemistry, University of Connecticut, Storrs, Connecticut 06269, United States

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2021 in ACS Nano
Verified
Journal Article
Open access
TGTyler D. Gavitt
Tyler D. Gavitt
AHAlyssa K. Hartmann
Alyssa K. Hartmann
SSShraddha S. Sawant
Shraddha S. Sawant
AMArlind Mara
Arlind Mara
SSSteven M. Szczepanek
Steven M. Szczepanek
Jessica RougeJessica Rouge
Jessica Rouge
Allergic asthma is one of the leading chronic lung diseases of both children and adults worldwide, resulting in significant morbidity and mortality in affected individuals. Many patients have severe asthma, which is refractory to treatment, illustrating the need for the development of new therapeutics for this disease. Herein, we describe the use of a peptide cross-linked nucleic acid nanocapsule (NAN) for the delivery of a GATA3-specific DNAzyme to immune cells, with demonstration of modulated transcriptional activity and behavior of those cells. The NAN, built from peptide cross-linked surfactants, is chemically designed to degrade under inflammation conditions releasing individual DNAzyme-surfactant conjugates in response to proteolytic enzymes. Using the NAN, GATA3 DNAzymes were delivered efficiently to human peripheral blood mononuclear cells, with clear evidence of uptake by CD4+ helper T cells without the need for harsh transfection agents. Knockdown of GATA3 was achieved in vitro using human Jurkat T cells, which express GATA3 under homeostatic conditions. Additionally, mice treated with DNAzyme-NANs during house dust mite (HDM)-induced asthma developed less severe allergic lung inflammation than HDM-only control mice, as measured by pulmonary eosinophilia. This study suggests that peptide cross-linked GATA3 DNAzyme-NANs may have the potential to decrease the severity of asthma symptoms in human patients, and development of this technology for human use warrants further investigation.

26 May 2023 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
SPSuman Pal
Suman Pal
IFIna F. de la Fuente
Ina F. de la Fuente
SSShraddha S. Sawant
Shraddha S. Sawant
JCJenna N. Cannata
Jenna N. Cannata
WHWu He
Wu He
Jessica RougeJessica Rouge
Jessica Rouge

12 August 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
IFIna F. de la Fuente
Ina F. de la Fuente
SSShraddha S. Sawant
Shraddha S. Sawant
KKKiang W. Kho
Kiang W. Kho
NSNirod K. Sarangi
Nirod K. Sarangi
RCRachelle Canete
Rachelle Canete
Jessica RougeJessica Rouge
Jessica Rouge

28 February 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
JSJoshua J. Santiana
Joshua J. Santiana
SSShraddha S. Sawant
Shraddha S. Sawant
NGNicole Gomez
Nicole Gomez
Jessica RougeJessica Rouge
Jessica Rouge
Controllable release of multiple distinct cargoes from a nanomaterial is crucial to a variety of therapeutic and catalytic applications. In this study, we describe a DNA functionalized multi-layered surface crosslinked micelle (mlSCM) consisting of individually degradable layers. The DNA modified mlSCM has the ability to encapsulate separate small molecule cargo in distinct compartments within the nanocapsule, separated by chemical crosslinkers. Through a multistep self-assembly process, we show physical separation of internalized cargo as evidenced by electron microscopy, along with observation of chemical control over release, and chemical reaction conditions, as seen by fluorescence spectroscopy and a high-performance liquid chromatography mass spectrometry assay. Additionally, we evaluated the ability of these DNA crosslinked micelles to co-release two separate cargoes into the same cellular environment through an in vitro confocal microscopy assay. We show individualized targeting of two distinct but related dyes for the detection of ATP and mitochondria. The colocalization of these dyes indicates that unique locations and signals related to cellular respiration can be identified using a single mlSCM. Through these studies we ultimately show that the mlSCM has a tailorable design with the potential to be applied to numerous applications, ranging from sensing to drug delivery.